Yugap Wellness, a science-led wellness brand focused on evidence-backed nutrition and holistic health, has appointed Dr Satish Singh as Board Member – Scientific Committee, reinforcing its commitment to clinically informed, safe, and compliant wellness solutions.

 

The appointment comes as Yugap sharpens its focus on scientific governance and regulatory rigor across its product portfolio.

 

Commenting on the development, Yashna Garg, Founder, Yugap Wellness, said, “Dr Satish Singh’s deep healthcare and pharmaceutical expertise, combined with his regulatory leadership, will play a pivotal role in strengthening our scientific direction. His experience across medicines, nutraceuticals, and food systems aligns strongly with our vision of building wellness solutions grounded in science and trust.”

 

Dr Singh brings over 18 years of experience across healthcare, pharmaceuticals, nutraceuticals, food, and Ayurveda. He has held senior leadership roles in quality assurance, regulatory affairs, and compliance at leading organizations including Zeon Lifesciences, Patanjali Ayurved, Hamdard Laboratories, Torrent Pharmaceuticals, Maiden Pharmaceuticals, and Ranbaxy Fine Chemicals.

 

A PhD in Pharmaceutical Sciences, Dr Singh has led global regulatory audits, product validations, and quality systems spanning therapeutic formulations, dietary supplements, and functional foods. His work has involved close engagement with regulatory authorities such as the USFDA, Natural and Non-prescription Health Products Directorate, Canada (NNHPD), FSSAI, AYUSH, and other international health bodies.

 

With this appointment, Yugap Wellness underscores its focus on embedding healthcare-grade quality, robust regulatory compliance, and scientific credibility into every stage of product development—ensuring its wellness offerings meet global safety and healthcare benchmarks.